Nicotinamide
- Generic Name
- Nicotinamide
- Brand Names
- Alertonic, Fortaplex, Infuvite, Infuvite Pediatric, Mvc-fluoride, Mvi Pediatric, Natafort, Neo-bex, Nicomide, Pregvit, Tandem Plus
- Drug Type
- Small Molecule
- Chemical Formula
- C6H6N2O
- CAS Number
- 98-92-0
- Unique Ingredient Identifier
- 25X51I8RD4
- Background
An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake.
- Indication
用于防治糙皮病等烟酸缺乏病，也用于防治心脏传导阻滞。
- Associated Conditions
- Gastrointestinal insufficiency, Hepatic Insufficiency, Macrocytic anemia, Secondary anemia, Vitamin Deficiency, Severe debilitation
- Associated Therapies
- Dietary and Nutritional Therapies, Nutritional supplementation, Dietary supplementation
Nutritional Support and Prophylaxis Doses of Azithromycin for Pregnant Women - Mumta Pregnant Women Trial
- Conditions
- Interventions
- First Posted Date
- 2019-07-09
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Vital Pakistan Trust
- Target Recruit Count
- 1884
- Registration Number
- NCT04012177
- Locations
- 🇵🇰
Peri-urban slum (Rehri Goth), Karachi, Sindh, Pakistan
Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial
- Conditions
- Interventions
- First Posted Date
- 2018-12-07
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Women's College Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT03769285
- Locations
- 🇨🇦
Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia
- First Posted Date
- 2018-12-03
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- RWTH Aachen University
- Registration Number
- NCT03761511
- Locations
- 🇫🇷
Service de génétique médicale - Hôpital La Pitié Salpetrière, Paris, France
🇦🇹Medical University Innsbruck, Innsbruck, Austria
🇮🇹Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
Study of Nicotinamide in Early Onset Preeclampsia
- First Posted Date
- 2018-02-01
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 23
- Registration Number
- NCT03419364
- Locations
- 🇺🇸
UNC at Chapel Hill, Chapel Hill, North Carolina, United States
DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.
- Conditions
- Interventions
- First Posted Date
- 2018-01-08
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- Universidad Autonoma de San Luis Potosí
- Target Recruit Count
- 28
- Registration Number
- NCT03392623
Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus
- Conditions
- Interventions
- First Posted Date
- 2017-08-24
- Last Posted Date
- 2021-02-02
- Target Recruit Count
- 40
- Registration Number
- NCT03260166
- Locations
- 🇨🇳
The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
Healthy Combine Study
- Conditions
- Interventions
- First Posted Date
- 2017-05-02
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 39
- Registration Number
- NCT03136705
- Locations
- 🇺🇸
Center for Translational Metabolism and Health (CTMH), Northwestern University, Chicago, Illinois, United States
Nicotinamide as an Early Alzheimer's Disease Treatment
- Conditions
- Interventions
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 46
- Registration Number
- NCT03061474
- Locations
- 🇺🇸
University of California, Irvine, Irvine, California, United States
🇺🇸University of California, Los Angeles, Los Angeles, California, United States
Anticancer Activity of Nicotinamide on Lung Cancer
- First Posted Date
- 2015-04-15
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Il Yeong Park, Ph.D.
- Target Recruit Count
- 110
- Registration Number
- NCT02416739
- Locations
- 🇰🇷
Chonnam National University Hwasun Hospital, Hwasun, Chonnam, Korea, Republic of
The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
- Conditions
- Interventions
- First Posted Date
- 2014-10-07
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 205
- Registration Number
- NCT02258074
- Locations
- 🇺🇸
NorthShore University Health System, Chicago, Illinois, United States
🇺🇸Denver Nephrology Research, Denver, Colorado, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.